Anbio Biotechnology (NNNN) Change in Accured Expenses (2024 - 2025)
Historic Change in Accured Expenses for Anbio Biotechnology (NNNN) over the last 2 years, with Q2 2025 value amounting to $70.8 billion.
- Anbio Biotechnology's Change in Accured Expenses changed N/A to $70.8 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $70.8 billion, marking a year-over-year change of. This contributed to the annual value of $105.0 billion for FY2024, which is 6453643498.58% up from last year.
- Anbio Biotechnology's Change in Accured Expenses amounted to $70.8 billion in Q2 2025.
- Anbio Biotechnology's Change in Accured Expenses' 5-year high stood at $105.0 billion during Q4 2024, with a 5-year trough of $70.8 billion in Q2 2025.